tradingkey.logo
tradingkey.logo
Search

Sanofi And Regeneron's Dupixent To Treat Chronic Spontaneous Urticaria Advances In EU With Positive CHMP Opinion

ReutersSep 22, 2025 4:32 AM
facebooktwitterlinkedin

- Sanofi SA SASY.PA:

  • PRESS RELEASE: SANOFI AND REGENERON’S DUPIXENT TO TREAT CHRONIC SPONTANEOUS URTICARIA ADVANCES IN EU WITH POSITIVE CHMP OPINION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI